Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 7/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.40 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 3/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28659130 | 0.81 | HTR2A (0.50) | MAOAMAOBHTR2ASLC6A4KCNH2 | |
| SCHEMBL895205 | 0.80 | IDO1 (0.54) | IDO1 | |
| SCHEMBL29439097 | 0.80 | IDO1 (0.54) | IDO1 | |
| SCHEMBL3647629 | 0.80 | SLC6A4 (0.43) | HTR2ASLC6A4KCNH2 | |
| SCHEMBL480070 | 0.79 | SLC6A4 (0.43) | HTR2ASLC6A4KCNH2IDO1MEN1 | |
| SCHEMBL6446133 | 0.78 | MAOB (0.48) | MAOAMAOBNR4A2PPARGPPARA | |
| SCHEMBL15823881 | 0.77 | AHR (0.45) | IDO1 | |
| SCHEMBL27585018 | 0.77 | NR4A2 (0.43) | MAOAMAOBHTR2ASLC6A4KCNH2 | |
| SCHEMBL15809203 | 0.75 | CHRM1 (0.48) | NR4A2PPARGPPARA | |
| SCHEMBL14793788 | 0.74 | L3MBTL1 (0.44) | MAOAMAOBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118108587-A | Method for preparing phenylate ketone bromide | 江苏扬农化工股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-100358855-C | Production method of 4- (4-chlorophenoxy) -2-chlorophenyl-methyl ketone | JIANGSU CHANGQING NONGHUA CO L (CN) | 2008-01-02 | — | — | CN | claimed |
| CN-1493557-A | Production method of 4- (4-chlorophenoxy) -2-chlorophenyl-methyl ketone | 江苏长青农化股份有限公司 | 2004-05-05 | — | — | CN | claimed |
| CN-118108587-A | Method for preparing phenylate ketone bromide | 江苏扬农化工股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108587-A | Method for preparing phenylate ketone bromide | 江苏扬农化工股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20150351401-A1 | SUBSTITUTED [1,2,4]TRIAZOLE AND IMIDAZOLE COMPOUNDS | BASF SE (DE) | 2015-12-10 | — | — | US | disclosed |
| EP-2935225-A1 | SUBSTITUTED [1,2,4]TRIAZOLE AND IMIDAZOLE COMPOUNDS | BASF SE (DE) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014095655-A1 | SUBSTITUTED [1,2,4]TRIAZOLE AND IMIDAZOLE COMPOUNDS | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
| EP-2746260-A1 | Substituted [1,2,4]triazole and imidazole compounds | BASF SE (DE) | 2014-06-25 | — | — | EP | disclosed |
| CN-100358855-C | Production method of 4- (4-chlorophenoxy) -2-chlorophenyl-methyl ketone | JIANGSU CHANGQING NONGHUA CO L (CN) | 2008-01-02 | — | — | CN | disclosed |
| CN-100358855-C | Production method of 4- (4-chlorophenoxy) -2-chlorophenyl-methyl ketone | JIANGSU CHANGQING NONGHUA CO L (CN) | 2008-01-02 | — | — | CN | disclosed |
| EP-1651631-A1 | BICYCLIC IMIDAZOL DERIVATIVES AGAINST FLAVIVIRIDAE | GENELABS TECHNOLOGIES, INC. (US) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005012288-A1 | BICYCLIC IMIDAZOL DERIVATIVES AGAINST FLAVIVIRIDAE | GENELABS TECHNOLOGIES, INC (US) | 2005-02-10 | — | — | WO | disclosed |
| CN-1493557-A | Production method of 4- (4-chlorophenoxy) -2-chlorophenyl-methyl ketone | 江苏长青农化股份有限公司 | 2004-05-05 | — | — | CN | disclosed |
| CN-1493557-A | Production method of 4- (4-chlorophenoxy) -2-chlorophenyl-methyl ketone | 江苏长青农化股份有限公司 | 2004-05-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150351401-A1 | SUBSTITUTED [1,2,4]TRIAZOLE AND IMIDAZOLE COMPOUNDS | CYP1B1, CYP4B1, COX4I1 | MAOA 224/4885MAOB 132/4885HTR2A 1473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.